Everything everywhere all at once
2023; American Association for the Advancement of Science; Volume: 8; Issue: 87 Linguagem: Inglês
10.1126/sciimmunol.adk4486
ISSN2470-9468
Autores Tópico(s)Monoclonal and Polyclonal Antibodies Research
ResumoIn successful melanoma immunotherapy, clonal TCRs can recognize multiple tumor-specific antigens simultaneously through cross-reactivity.
Referência(s)